Peptide Lexicon

Retatrutide

Retatrutide in the T&T Supplies peptide lexicon: research reference with mechanism, reported effects, limitations and literature data. Evidence grade A-.

Mechanism

Triple-agonist: GIP/GLP-1/GCGR receptor agonist. Activates all three incretin pathways simultaneously. More potent weight loss signal than dual agonists. Enhances hepatic glucose production control.

Reported effects

Superior weight loss vs dual agonists. Best metabolic control profile. Strongest satiety signal. Lowest relapse risk post-cycle. Lean mass sparing excellent.

Limitations

Newer molecule — longer-term safety data still accumulating. GLP-1 class side effects during titration. Expensive. Off-label use for performance.

Literature data

Dosage (literature)

0.5-2.5mg weekly subcut. Titrate over 12-16 weeks

Timing

Weekly injection any time

Cycling

Continuous once titrated. Maintenance phase.

Retatrutide in the shop

Information for research purposes only.